Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

Stijn Hees, S Bourgeois, H van Vlierberghe, T Serste, S Francque, P Michielsen, D Sprengers, H Reynaert, J Henrion, SN Dastis, J Delwaide, L Lasser, J Decaestecker, H Orlent, F Janssens, G Robaeys, I Colle, P Starkel, C Moreno, F NevensThomas Vanwolleghem

Research output: Contribution to journalArticleAcademicpeer-review

33 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1170-1180
Number of pages11
JournalAlimentary Pharmacology & Therapeutics
Volume47
Issue number8
DOIs
Publication statusPublished - 2018

Cite this